Yüklüyor......
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
Most breast cancers express estrogen receptor (ER) α, and the antiestrogen drug tamoxifen has been widely used for their treatment. Unfortunately, up to half of all ERα-positive tumors have intrinsic or acquired endocrine therapy resistance. Our recent studies revealed that the ER coactivator Mediat...
Kaydedildi:
| Yayımlandı: | ACS Nano |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488869/ https://ncbi.nlm.nih.gov/pubmed/27966906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsnano.6b05910 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|